FindTrial
Sign In

Follitropin Alfa (GONAL-F)

DRUG6 trials

Sponsors

Ferring Pharmaceuticals, IVFarma LLC, Stella Maris Women and Children Hospital

Conditions

AbsorptionArea Under CurveInfertilityInfertility, FemaleInsemination, ArtificialOvulation InductionPharmacokinetics

Phase 1

The Safety and Pharmacokinetics of Primapur and Gonal-f
CompletedNCT03857230
IVFarma LLCAbsorption, Area Under Curve, Pharmacokinetics
Start: 2015-10-29End: 2016-05-10Updated: 2019-08-13

Phase 3

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1
CompletedNCT01956110
Ferring PharmaceuticalsInfertility
Start: 2013-10-31End: 2017-01-03Updated: 2022-01-13
Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2
CompletedNCT01956123
Ferring PharmaceuticalsInfertility
Start: 2014-03-26End: 2017-01-03Updated: 2023-09-06
Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment
CompletedNCT03088137
IVFarma LLCInfertility, Female
Start: 2017-02-08End: 2018-08-17Updated: 2022-04-01
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Women
CompletedNCT04773353
Ferring PharmaceuticalsInfertility
Start: 2021-12-03End: 2023-12-12Updated: 2025-01-24

Unknown Phase

Follitropin Delta Versus Follitropin Alfa in Indonesian Women Undergoing IUI
CompletedNCT07801781
Stella Maris Women and Children HospitalInfertility, Insemination, Artificial, Ovulation Induction
Start: 2020-01-01End: 2022-12-31Updated: 2026-09-03

Related Papers

Cost-Effectiveness of Follitropin Delta Compared with Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in France.
2026-03-11
O-014 Cumulative live birth associated with number of oocytes in ovarian stimulation with follitropin delta: an individual patient data meta-analysis
Human Reproduction2024-07-01
P-605 Effectiveness of follitropin delta in patients with potential poor response: A post hoc analysis from the ESTHER-1 trial
Human Reproduction2024-07-01
P-680 Comparison of ovarian hyperstimulation syndrome (OHSS) rates resulting from conventional dosing versus personalized dosing of follitropin delta in ovarian stimulation, analysis of RITA, ESTHER-1 trials
Human Reproduction2024-07-01
O-013 Population pharmacokinetics of follitropin delta during ovarian stimulation
Human Reproduction2024-07-01
P-655 Live birth rate in the fresh cycle associated with number of oocytes in ovarian stimulation with individualised follitropin delta: an individual patient data meta-analysis
Human Reproduction2024-07-01
P-667 Follitropin delta for ovarian stimulation in daily practice in a Dutch IVF centre
Human Reproduction2022-06-29
Association of the Serum Folate and Total Calcium and Magnesium Levels Before Ovarian Stimulation With Outcomes of Fresh In Vitro Fertilization Cycles in Normogonadotropic Women
Frontiers in Endocrinology2022-02-1117 citations
Comparison of ovarian response to follitropin delta in Japanese and White IVF/ICSI patients.
2021-09-234 citations
Pregnancy and neonatal outcomes in fresh and frozen cycles using blastocysts derived from ovarian stimulation with follitropin delta.
2021-07-1310 citations
O-114 Improved safety and efficiency of individualised versus conventional gonadotropin dosing for ovarian stimulation in IVF/ICSI: an individual patient meta-analysis (IPD-MA)
Human Reproduction2021-07-013 citations
P–650 Body weight is the main determinant of systemic follicle stimulating hormone (FSH) concentrations during controlled ovarian stimulation with follitropin delta
Human Reproduction2021-07-013 citations
P–586 Clinical outcome in frozen cycles using cryopreserved blastocysts derived from ovarian stimulation with follitropin delta
Human Reproduction2021-07-01
A multicenter, randomized, phase III study comparing the efficacy and safety of follitropin alpha biosimilar and the original follitropin alpha.
2019-07-2616 citations
Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles.
2018-12-2327 citations
Major results of a phase III comparative multicenter study on the follitropin alfa biosimilar (Primapur®) and the original follitropin alfa (Gonal-f®)
Obstetrics Gynecology and Reproduction2018-11-205 citations
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
2016-11-29182 citations